184 related articles for article (PubMed ID: 31433854)
1. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India.
Mukherjee MB; Colah RB; Mehta PR; Shinde N; Jain D; Desai S; Dave K; Italia Y; Raicha B; Serrao E
Am J Clin Pathol; 2020 Jan; 153(1):82-87. PubMed ID: 31433854
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
[TBL] [Abstract][Full Text] [Related]
3. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
[TBL] [Abstract][Full Text] [Related]
4. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood.
Guindo A; Cisse Z; Keita I; Desmonde S; Sarro YDS; Touré BA; Baraika MA; Tessougué O; Guindo P; Coulibaly M; Traore O; Sylla N; Diassana M; Saye A; Picot V; Lauressergues E; Leroy V
Br J Haematol; 2024 Jan; 204(1):337-345. PubMed ID: 37728227
[TBL] [Abstract][Full Text] [Related]
5. Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria.
Okeke CO; Chianumba RI; Isa H; Asala S; Nnodu OE
Front Genet; 2022; 13():1013858. PubMed ID: 36386848
[No Abstract] [Full Text] [Related]
6. Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.
McGann PT; Schaefer BA; Paniagua M; Howard TA; Ware RE
Am J Hematol; 2016 Feb; 91(2):205-10. PubMed ID: 26537622
[TBL] [Abstract][Full Text] [Related]
7. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
Nnodu O; Isa H; Nwegbu M; Ohiaeri C; Adegoke S; Chianumba R; Ugwu N; Brown B; Olaniyi J; Okocha E; Lawson J; Hassan AA; Diaku-Akinwumi I; Madu A; Ezenwosu O; Tanko Y; Kangiwa U; Girei A; Israel-Aina Y; Ladu A; Egbuzu P; Abjah U; Okolo A; Akbulut-Jeradi N; Fernandez M; Piel FB; Adekile A
Blood Cells Mol Dis; 2019 Sep; 78():22-28. PubMed ID: 30773433
[TBL] [Abstract][Full Text] [Related]
8. Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN™) in Screening for Sickle Cell Disease.
Nwegbu MM; Isa HA; Nwankwo BB; Okeke CC; Edet-Offong UJ; Akinola NO; Adekile AD; Aneke JC; Okocha EC; Ulasi T; Abjah U; Ugwu NI; Okolo AA; Madu A; Emodi I; Girei A; Balogun TM; Diaku-Akinwumi IN; Ohiaeri C; Brown BJ; Olaniyi JA; Hassan A; Awwalu S; Okoh DA; Nnodu OE
Hemoglobin; 2017 Mar; 41(2):77-82. PubMed ID: 28617057
[TBL] [Abstract][Full Text] [Related]
9. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.
Quinn CT; Paniagua MC; DiNello RK; Panchal A; Geisberg M
Br J Haematol; 2016 Nov; 175(4):724-732. PubMed ID: 27605462
[TBL] [Abstract][Full Text] [Related]
10. Newborn screening for sickle cell disease in Kisangani, Democratic Republic of the Congo: an update.
Kasai ET; Gulbis B; Ntukamunda JK; Bours V; Batina Agasa S; Marini Djang'eing'a R; Boemer F; Katenga Bosunga G; Ngbonda Dauly N; Sokoni Vutseme J; Boso Mokili B; Alworong'a Opara JP
Hematology; 2023 Dec; 28(1):2213043. PubMed ID: 37183964
[TBL] [Abstract][Full Text] [Related]
11. Validation of a novel point of care testing device for sickle cell disease.
Kanter J; Telen MJ; Hoppe C; Roberts CL; Kim JS; Yang X
BMC Med; 2015 Sep; 13():225. PubMed ID: 26377572
[TBL] [Abstract][Full Text] [Related]
12. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios.
Allaf B; Patin F; Elion J; Couque N
Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571
[TBL] [Abstract][Full Text] [Related]
13. Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies.
Eastman JW; Wong R; Liao CL; Morales DR
Clin Chem; 1996 May; 42(5):704-10. PubMed ID: 8653895
[TBL] [Abstract][Full Text] [Related]
14. [Targeted newborn screening for sickle-cell anemia: Sickling test (Emmel test) boundaries in the prenatal assessment in West African area].
Diallo DA; Guindo A; Touré BA; Sarro YS; Sima M; Tessougué O; Baraika MA; Guindo P; Traoré M; Diallo M; Dorie A
Rev Epidemiol Sante Publique; 2018 May; 66(3):181-185. PubMed ID: 29625861
[TBL] [Abstract][Full Text] [Related]
15. Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.
Nguyen-Khoa T; Mine L; Allaf B; Ribeil JA; Remus C; Stanislas A; Gauthereau V; Enouz S; Kim JS; Yang X; Gluckman E; Beaudeux JL; Munnich A; Girot R; Cavazzana M
Ann Biol Clin (Paris); 2018 Aug; 76(4):416-420. PubMed ID: 29976532
[TBL] [Abstract][Full Text] [Related]
16. Detection of the beta s gene: an evaluation of the solubility test against automated chromatography and haemoglobin electrophoresis.
Surve RR; Mukherjee MB; Kate SL; Nagtilak SB; Wadia M; Tamankar AA; Ghosh K; Colah RB; Mohanty D
Br J Biomed Sci; 2000; 57(4):292-4. PubMed ID: 11204858
[TBL] [Abstract][Full Text] [Related]
17. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
[TBL] [Abstract][Full Text] [Related]
18. Newborn screening shows a high incidence of sickle cell anemia in Central India.
Jain DL; Sarathi V; Upadhye D; Gulhane R; Nadkarni AH; Ghosh K; Colah RB
Hemoglobin; 2012; 36(4):316-22. PubMed ID: 22712682
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of HemotypeSC as a Point-of-Care Testing Device for Sickle Cell Disease: Findings from a Southwestern State in Nigeria and Implications for Patient Care in Resource-Poor Settings of sub-Saharan Africa.
Olatunya OS; Albuquerque DM; Fagbamigbe AF; Faboya OA; Ajibola AE; Babalola OA; Adebisi AO; Falusi AG; Adekile A; Costa FF
Glob Pediatr Health; 2021; 8():2333794X211016789. PubMed ID: 34046518
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of clinical presentation and hematological indices in hospitalized sickle cell patients with severe Plasmodium falciparum malaria.
Purohit P; Mohanty PK; Patel S; Das P; Panigrahi J; Das K
J Infect Public Health; 2018; 11(3):321-325. PubMed ID: 28927555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
